These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines. Sato K, Tomioka H, Akaki T, Kawahara S. Int J Antimicrob Agents; 2000 Sep; 16(1):25-9. PubMed ID: 11185410 [Abstract] [Full Text] [Related]
9. Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine. Rastogi N, Goh KS, Bryskier A, Devallois A. Antimicrob Agents Chemother; 1996 Nov; 40(11):2483-7. PubMed ID: 8913450 [Abstract] [Full Text] [Related]
17. Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model. Bermudez LE, Nash KA, Petrofsky M, Young LS, Inderlied CB. J Infect Dis; 1996 Dec; 174(6):1218-22. PubMed ID: 8940212 [Abstract] [Full Text] [Related]
19. Comparative in-vitro activity of Bay y 3118, a new quinolone, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Sirgel FA, Venter A, Heilmann HD. J Antimicrob Chemother; 1995 Feb; 35(2):349-51. PubMed ID: 7759400 [No Abstract] [Full Text] [Related]